Daring to believe that a cure can be a reality
IPI-549 Development
Discover
Infinity Receives Fast Track Designation for Eganelisib in Combination with a Checkpoint Inhibitor and Chemotherapy for First-Line Treatment of Advanced TNBC
Read the Details
Role of PI3K-gamma
Learn More
